First Tracks Biotherapeutics, Inc. (TRAXV) at a glance

First Tracks Biotherapeutics, Inc. (TRAXV) is a small-cap Healthcare company. It trades at $17.66, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 50/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Momentum (30/100).

Price
$17.66
Market cap
$613.5M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$14.72 to $26.80
Vestovix Score50/ 100How this works
Value
53
Growth
50
Income
40
Safety
66
Momentum
30

Other Healthcare stocks

See all